Drawing for ASPIRINA

USPTO serial 76148955

ASPIRINA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
MADDEN, ANNE
Law office
TMEG LAW OFFICE 103 - DOCKET CLERK

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ASPIRINA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stanley C. Macel, III

STANLEY C MACEL III CONNOLLY BOVE LODGE & HUTZ LLP1220 MARKET STP O BOX 2207WILMINGTON, DE 19899

Goods and services

ClassDescriptionStatusFirst use
005analgesicsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2005DOCKASSIGNED TO EXAMINER
Apr 23, 2003ABN1ABANDONMENT - EXPRESS MAILED
Mar 27, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2003MAILPAPER RECEIVED
Dec 11, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance